47,733 Shares in Lantheus Holdings, Inc. (LNTH) Acquired by Teachers Advisors LLC
Teachers Advisors LLC bought a new position in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 47,733 shares of the medical equipment provider’s stock, valued at approximately $842,000. Teachers Advisors LLC owned about 0.13% of Lantheus Holdings at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Royce & Associates LP purchased a new position in shares of Lantheus Holdings during the second quarter worth $4,896,000. Bank of New York Mellon Corp raised its holdings in shares of Lantheus Holdings by 6.3% during the first quarter. Bank of New York Mellon Corp now owns 68,473 shares of the medical equipment provider’s stock worth $856,000 after purchasing an additional 4,084 shares during the last quarter. Prudential Financial Inc. purchased a new position in shares of Lantheus Holdings during the second quarter worth $835,000. California Public Employees Retirement System raised its holdings in shares of Lantheus Holdings by 29.2% during the first quarter. California Public Employees Retirement System now owns 77,800 shares of the medical equipment provider’s stock worth $973,000 after purchasing an additional 17,600 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. purchased a new position in shares of Lantheus Holdings during the second quarter worth $770,000. 85.03% of the stock is owned by hedge funds and other institutional investors.
Lantheus Holdings, Inc. (NASDAQ LNTH) opened at $22.30 on Friday. Lantheus Holdings, Inc. has a fifty-two week low of $7.95 and a fifty-two week high of $23.00. The company has a debt-to-equity ratio of -3.05, a current ratio of 2.92 and a quick ratio of 2.43. The firm has a market cap of $836.38, a price-to-earnings ratio of 19.91, a price-to-earnings-growth ratio of 1.63 and a beta of 0.92.
Lantheus Holdings (NASDAQ:LNTH) last released its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.24 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.04. Lantheus Holdings had a net margin of 9.59% and a negative return on equity of 44.05%. The company had revenue of $79.94 million during the quarter, compared to analysts’ expectations of $77.18 million. During the same quarter in the previous year, the company earned $0.15 earnings per share. The firm’s revenue for the quarter was up 9.4% on a year-over-year basis. equities research analysts expect that Lantheus Holdings, Inc. will post 1.1 EPS for the current fiscal year.
LNTH has been the subject of several recent research reports. BidaskClub cut shares of Lantheus Holdings from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 17th. Credit Suisse Group raised their target price on shares of Lantheus Holdings from $14.00 to $19.00 and gave the stock a “neutral” rating in a report on Wednesday, August 2nd. Zacks Investment Research raised shares of Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $18.00 target price for the company in a report on Thursday, August 3rd. Wells Fargo & Company raised shares of Lantheus Holdings from a “market perform” rating to an “outperform” rating in a report on Thursday. Finally, Cantor Fitzgerald started coverage on shares of Lantheus Holdings in a report on Monday, July 17th. They issued an “overweight” rating and a $22.00 price objective for the company. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $20.40.
In other Lantheus Holdings news, major shareholder Avista Capital Partners Gp, Ll sold 87,939 shares of Lantheus Holdings stock in a transaction on Monday, August 14th. The shares were sold at an average price of $17.40, for a total value of $1,530,138.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Cesare Orlandi sold 18,000 shares of Lantheus Holdings stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $16.69, for a total transaction of $300,420.00. Following the completion of the transaction, the insider now directly owns 87,078 shares of the company’s stock, valued at approximately $1,453,331.82. The disclosure for this sale can be found here. Insiders sold 903,099 shares of company stock valued at $15,443,485 in the last ninety days. 2.30% of the stock is owned by corporate insiders.
About Lantheus Holdings
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.